Literature DB >> 23414320

Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines.

Aslihan Dagdemir1, Julie Durif, Marjolaine Ngollo, Yves-Jean Bignon, Dominique Bernard-Gallon.   

Abstract

AIM: The isoflavones genistein, daidzein and equol (daidzein metabolite) have been reported to interact with epigenetic modifications, specifically hypermethylation of tumor suppressor genes. The objective of this study was to analyze and understand the mechanisms by which phytoestrogens act on chromatin in breast cancer cell lines. MATERIALS &
METHODS: Two breast cancer cell lines, MCF-7 and MDA-MB 231, were treated with genistein (18.5 µM), daidzein (78.5 µM), equol (12.8 µM), 17β-estradiol (10 nM) and suberoylanilide hydroxamic acid (1 µM) for 48 h. A control with untreated cells was performed. 17β-estradiol and an anti-HDAC were used to compare their actions with phytoestrogens. The chromatin immunoprecipitation coupled with quantitative PCR was used to follow soy phytoestrogen effects on H3 and H4 histones on H3K27me3, H3K9me3, H3K4me3, H4K8ac and H3K4ac marks, and we selected six genes (EZH2, BRCA1, ERα, ERβ, SRC3 and P300) for analysis.
RESULTS: Soy phytoestrogens induced a decrease in trimethylated marks and an increase in acetylating marks studied at six selected genes.
CONCLUSION: We demonstrated that soy phytoestrogens tend to modify transcription through the demethylation and acetylation of histones in breast cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23414320     DOI: 10.2217/epi.12.74

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  24 in total

Review 1.  Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach.

Authors:  Sona Uramova; Peter Kubatka; Zuzana Dankova; Andrea Kapinova; Barbora Zolakova; Marek Samec; Pavol Zubor; Anthony Zulli; Vanda Valentova; Taeg Kyu Kwon; Peter Solar; Martin Kello; Karol Kajo; Dietrich Busselberg; Martin Pec; Jan Danko
Journal:  EPMA J       Date:  2018-11-12       Impact factor: 6.543

2.  Daidzein Synergizes with Gefitinib to Induce ROS/JNK/c-Jun Activation and Inhibit EGFR-STAT/AKT/ERK Pathways to enhance Lung Adenocarcinoma cells chemosensitivity.

Authors:  Thomas Gabriel Mhone; Ming-Cheng Chen; Chia-Hua Kuo; Tzu-Ching Shih; Chung-Min Yeh; Tso-Fu Wang; Ray-Jade Chen; Yu-Chun Chang; Wei-Wen Kuo; Chih-Yang Huang
Journal:  Int J Biol Sci       Date:  2022-05-16       Impact factor: 10.750

Review 3.  Influence of maternal obesity, diet and exercise on epigenetic regulation of adipocytes.

Authors:  Archana Dhasarathy; James N Roemmich; Kate J Claycombe
Journal:  Mol Aspects Med       Date:  2016-11-04

Review 4.  Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors.

Authors:  Eunah Kim; William H Bisson; Christiane V Löhr; David E Williams; Emily Ho; Roderick H Dashwood; Praveen Rajendran
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 5.  Endocrine disruption of the epigenome: a breast cancer link.

Authors:  Kevin C Knower; Sarah Q To; Yuet-Kin Leung; Shuk-Mei Ho; Colin D Clyne
Journal:  Endocr Relat Cancer       Date:  2014-03-12       Impact factor: 5.678

Review 6.  Dietary Phytoestrogens and Their Metabolites as Epigenetic Modulators with Impact on Human Health.

Authors:  Victor Stefan Ionescu; Alexandra Popa; Andrei Alexandru; Emilia Manole; Mihaela Neagu; Sevinci Pop
Journal:  Antioxidants (Basel)       Date:  2021-11-26

Review 7.  The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions.

Authors:  Abdelhakim Bouyahya; Hamza Mechchate; Loubna Oumeslakht; Ikrame Zeouk; Sara Aboulaghras; Abdelaali Balahbib; Gokhan Zengin; Mohammad Amjad Kamal; Monica Gallo; Domenico Montesano; Nasreddine El Omari
Journal:  Biomolecules       Date:  2022-02-25

Review 8.  BRCA1 and p53 tumor suppressor molecules in Alzheimer's disease.

Authors:  Atsuko Nakanishi; Akari Minami; Yasuko Kitagishi; Yasunori Ogura; Satoru Matsuda
Journal:  Int J Mol Sci       Date:  2015-01-28       Impact factor: 5.923

9.  Epigenetic activities of flavonoids in the prevention and treatment of cancer.

Authors:  Christian Busch; Markus Burkard; Christian Leischner; Ulrich M Lauer; Jan Frank; Sascha Venturelli
Journal:  Clin Epigenetics       Date:  2015-07-10       Impact factor: 6.551

Review 10.  Recent Advances in Heterologous Synthesis Paving Way for Future Green-Modular Bioindustries: A Review With Special Reference to Isoflavonoids.

Authors:  Moon Sajid; Shane Ramsay Stone; Parwinder Kaur
Journal:  Front Bioeng Biotechnol       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.